Forest Laboratories (FRA:FQX) Days Payable : 54.77 (As of Mar. 2014)

View and export this data going back to . Start your Free Trial

What is Forest Laboratories Days Payable?

Forest Laboratories's average Accounts Payable for the three months ended in Mar. 2014 was €108 Mil. Forest Laboratories's Cost of Goods Sold for the three months ended in Mar. 2014 was €180 Mil. Hence, Forest Laboratories's Days Payable for the three months ended in Mar. 2014 was 54.77.

The historical rank and industry rank for Forest Laboratories's Days Payable or its related term are showing as below:

FRA:FQX' s Days Payable Range Over the Past 10 Years
Min: 0 Med: 0 Max: 106.06
Current: 106.06

During the past 13 years, Forest Laboratories's highest Days Payable was 106.06. The lowest was 0.00. And the median was 0.00.

FRA:FQX's Days Payable is not ranked
in the Drug Manufacturers industry.
Industry Median: 88.685 vs FRA:FQX: 106.06

Forest Laboratories's Days Payable declined from Mar. 2013 (60.02) to Mar. 2014 (54.77). It may suggest that Forest Laboratories accelerated paying its suppliers.

Forest Laboratories Days Payable Historical Data

The historical data trend for Forest Laboratories's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forest Laboratories Days Payable Chart

Forest Laboratories Annual Data

Trend

Mar05

Mar06

Mar07

Mar08

Mar09

Mar10

Mar11

Mar12

Mar13

Mar14

Days Payable

Get a 7-Day Free Trial

49.76

61.60

61.06

86.77

93.34

Forest Laboratories Quarterly Data
	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14
Days Payable	Get a 7-Day Free Trial															60.02	83.51	58.77	36.47	54.77

Competitive Comparison of Forest Laboratories's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Forest Laboratories's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Forest Laboratories's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Forest Laboratories's Days Payable distribution charts can be found below:

* The bar in red indicates where Forest Laboratories's Days Payable falls into.

Forest Laboratories Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Forest Laboratories's Days Payable for the fiscal year that ended in Mar. 2014 is calculated as

	Days Payable (A: Mar. 2014 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2013 )	+	Accounts Payable (A: Mar. 2014 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2014 )	*	Days in Period
=	( (121.473	+	159.801)	/	2 )	/	549.944	*	365
=	140.637					/	549.944	*	365
=	93.34

Forest Laboratories's Days Payable for the quarter that ended in Mar. 2014 is calculated as:

	Days Payable (Q: Mar. 2014 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2013 )	+	Accounts Payable (Q: Mar. 2014 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2014 )	*	Days in Period
=	( (56.551	+	159.801)	/	2 )	/	180.235	*	365 / 4
=	108.176					/	180.235	*	365 / 4
=	54.77

Forest Laboratories Days Payable Related Terms

Thank you for viewing the detailed overview of Forest Laboratories's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Forest Laboratories (FRA:FQX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Forest Laboratories Inc (FRA:FQX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.frx.com

Forest Laboratories, Inc. is a Delaware corporation organized in 1956. The Company develops, manufactures and sells branded forms of ethical drug products most of which require a physician's prescription. The Company's most important United States products are marketed directly, or 'detailed,' to physicians by its salesforces. It emphasizes detailing to physicians of those branded ethical drugs which have the most potential for growth and benefit to patients. The Company also develops and introduces new products, including products developed in collaboration with licensing partners. The Company's products include those developed by it and those acquired from other pharmaceutical companies and integrated into its marketing and distribution systems. It actively promotes in the United States those branded products which have the most potential for growth and patient benefit, and which enable its salesforces to concentrate on groups of physicians who are high prescribers of its products. Such products include: Lexapro, its SSRI for the treatment of major depression in adults and adolescents and GAD in adults; Namenda, its NMDA antagonist for the treatment of moderate and severe Alzheimer's disease; Bystolic, its beta-blocker for the treatment of hypertension; and Savella, its newest product, an SNRI for the management of fibromyalgia. The Company's United Kingdom and Ireland subsidiaries sell both ethical products and over-the-counter preparations. Their most important products include Sudocrem, a topical preparation for the treatment of diaper rash; Colomycin, an antibiotic used in the treatment of cystic fibrosis; Infacol, used to treat infant colic; and Exorex, used in the treatment of eczema and psoriasis. The pharmaceutical industry is subject to comprehensive government regulation which substantially increases the difficulty and cost incurred in obtaining the approval to market newly proposed drug products and maintaining the approval to market existing drugs.

Forest Laboratories (FRA:FQX) Headlines

No Headlines